Probiotics and prebiotics in ulcerative colitis

Best Practice and Research: Clinical Gastroenterology

Volumn 30, Issue 1, 2016, Pages 55-71

  Derikx, Lauranne A A P ^a   Dieleman, Levinus A ^b   Hoentjen, Frank ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Microbiota; Prebiotics; Probiotics; Ulcerative colitis

Indexed keywords

ESCHERICHIA COLI NISSLE 1917; PREBIOTIC AGENT; PROBIOTIC AGENT; UNCLASSIFIED DRUG; VSL3;

ARTICLE; BACTERIAL STRAIN; ESCHERICHIA COLI; HUMAN; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; NONHUMAN; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; ULCERATIVE COLITIS; COLITIS, ULCERATIVE; DISEASE MANAGEMENT; MICROBIOLOGY; PHYSIOLOGY;

COLITIS, ULCERATIVE; DISEASE MANAGEMENT; ESCHERICHIA COLI; GASTROINTESTINAL MICROBIOME; HUMANS; PREBIOTICS; PROBIOTICS; REMISSION INDUCTION;

EID: 84962439695     PISSN: 15216918     EISSN: 15321916     Source Type: Journal    
DOI: 10.1016/j.bpg.2016.02.005     Document Type: Review

References (70)

1. A.N. Ananthakrishnan Epidemiology and risk factors for IBD Nat Rev Gastroenterol Hepatol 12 2015 205 217
2. P. Frei, L. Biedermann, O.H. Nielsen, and G. Rogler Use of thiopurines in inflammatory bowel disease World J Gastroenterol WJG 19 2013 1040 1048
3. P. Andersson, and J.D. Soderholm Surgery in ulcerative colitis: indication and timing Dig Dis 27 2009 335 340
4. R.B. Sartor Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis Nat Clin Pract Gastroenterol Hepatol 3 2006 390 407
5. M. Campieri, and P. Gionchetti Probiotics in inflammatory bowel disease: new insight to pathogenesis or a possible therapeutic alternative? Gastroenterol 116 1999 1246 1249
6. A. Swidsinski, A. Ladhoff, A. Pernthaler, S. Swidsinski, V. Loening-Baucke, M. Ortner, and et al. Mucosal flora in inflammatory bowel disease Gastroenterology 122 2002 44 54
7. G.R. D'Haens, K. Geboes, M. Peeters, F. Baert, F. Penninckx, and P. Rutgeerts Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum Gastroenterology 114 1998 262 267
8. H.D. Janowitz, E.C. Croen, and D.B. Sachar The role of the fecal stream in Crohn's disease: an historical and analytic review Inflamm Bowel Dis 4 1998 29 39
9. P. Rutgeerts, K. Goboes, M. Peeters, M. Hiele, F. Penninckx, R. Aerts, and et al. Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum Lancet 338 1991 771 774
10. W. Wellmann, P.C. Fink, F. Benner, and F.W. Schmidt Endotoxaemia in active Crohn's disease. Treatment with whole gut irrigation and 5-aminosalicylic acid Gut 27 1986 814 820
11. K.J. Khan, T.A. Ullman, A.C. Ford, M.T. Abreu, A. Abadir, J.K. Marshall, and et al. Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis Am J Gastroenterol 106 2011 661 673
12. L. Jostins, S. Ripke, R.K. Weersma, R.H. Duerr, D.P. McGovern, K.Y. Hui, and et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease Nature 491 2012 119 124
13. P. Moayyedi, M.G. Surette, P.T. Kim, J. Libertucci, M. Wolfe, C. Onischi, and et al. Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial Gastroenterology 149 2015 102-9 e6
14. S.M. Jandhyala, R. Talukdar, C. Subramanyam, H. Vuyyuru, M. Sasikala, and D. Nageshwar Reddy Role of the normal gut microbiota World J Gastroenterol WJG 21 2015 8787 8803
15. P.B. Eckburg, E.M. Bik, C.N. Bernstein, E. Purdom, L. Dethlefsen, M. Sargent, and et al. Diversity of the human intestinal microbial flora Science 308 2005 1635 1638
16. D.N. Frank, A.L. St Amand, R.A. Feldman, E.C. Boedeker, N. Harpaz, and N.R. Pace Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases Proc Natl Acad Sci U S A 104 2007 13780 13785
17. H. Takaishi, T. Matsuki, A. Nakazawa, T. Takada, S. Kado, T. Asahara, and et al. Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease Int J Med Microbiol IJMM 298 2008 463 472
18. D. Jonkers, J. Penders, A. Masclee, and M. Pierik Probiotics in the management of inflammatory bowel disease: a systematic review of intervention studies in adult patients Drugs 72 2012 803 823
19. M. Arumugam, J. Raes, E. Pelletier, D. Le Paslier, T. Yamada, D.R. Mende, and et al. Enterotypes of the human gut microbiome Nature 473 2011 174 180
20. Y.A. Ghouri, D.M. Richards, E.F. Rahimi, J.T. Krill, K.A. Jelinek, and A.W. DuPont Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease Clin Exp Gastroenterol 7 2014 473 487
21. R.B. Sartor Microbial influences in inflammatory bowel diseases Gastroenterology 134 2008 577 594
22. P. Mallon, D. McKay, S. Kirk, and K. Gardiner Probiotics for induction of remission in ulcerative colitis Cochrane Database Syst Rev 2007 CD005573
23. R. Orel, and T. Kamhi Trop Intestinal microbiota, probiotics and prebiotics in inflammatory bowel disease World J Gastroenterol WJG 20 2014 11505 11524
24. M. Bellavia, G. Tomasello, M. Romeo, P. Damiani, A.I. Lo Monte, L. Lozio, and et al. Gut microbiota imbalance and chaperoning system malfunction are central to ulcerative colitis pathogenesis and can be counteracted with specifically designed probiotics: a working hypothesis Med Microbiol Immunol 202 2013 393 406
25. A. Nagasaki, H. Takahashi, M. Iinuma, T. Uchiyama, S. Watanabe, T. Koide, and et al. Ulcerative colitis with multidrug-resistant Pseudomonas aeruginosa infection successfully treated with bifidobacterium Digestion 81 2010 204 205
26. R. Chibbar, and L.A. Dieleman Probiotics in the management of ulcerative colitis J Clin Gastroenterol 49 Suppl. 1 2015 S50 S55
27. H. Matthes, T. Krummenerl, M. Giensch, C. Wolff, and J. Schulze Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN) BMC Complement Altern Med 10 2010 13
28. B.J. Rembacken, A.M. Snelling, P.M. Hawkey, D.M. Chalmers, and A.T. Axon Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial Lancet 354 1999 635 639
29. A.M. Petersen, H. Mirsepasi, S.I. Halkjaer, E.M. Mortensen, I. Nordgaard-Lassen, and K.A. Krogfelt Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis: a double-blind randomized placebo controlled clinical trial J Crohn's Colitis 8 2014 1498 1505
30. H.Q. Huynh, J. deBruyn, L. Guan, H. Diaz, M. Li, S. Girgis, and et al. Probiotic preparation VSL#3 induces remission in children with mild to moderate acute ulcerative colitis: a pilot study Inflamm Bowel Dis 15 2009 760 768
31. A. Sood, V. Midha, G.K. Makharia, V. Ahuja, D. Singal, P. Goswami, and et al. The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc 7 2009 1202-9, 9 e1
32. R. Bibiloni, R.N. Fedorak, G.W. Tannock, K.L. Madsen, P. Gionchetti, M. Campieri, and et al. VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis Am J Gastroenterol 100 2005 1539 1546
33. E. Miele, F. Pascarella, E. Giannetti, L. Quaglietta, R.N. Baldassano, and A. Staiano Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis Am J Gastroenterol 104 2009 437 443
34. S.C. Ng, S. Plamondon, M.A. Kamm, A.L. Hart, H.O. Al-Hassi, T. Guenther, and et al. Immunosuppressive effects via human intestinal dendritic cells of probiotic bacteria and steroids in the treatment of acute ulcerative colitis Inflamm Bowel Dis 16 2010 1286 1298
35. I. Soo, K.L. Madsen, Q. Tejpar, B.C. Sydora, R. Sherbaniuk, B. Cinque, and et al. VSL#3 probiotic upregulates intestinal mucosal alkaline sphingomyelinase and reduces inflammation Can J Gastroenterol J Can de Gastroenterol 22 2008 237 242
36. A. Tursi, G. Brandimarte, G.M. Giorgetti, G. Forti, M.E. Modeo, and A. Gigliobianco Low-dose balsalazide plus a high-potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitis Med Sci Monit Int Med J Exp Clin Res 10 2004 PI126 PI131
37. A. Tursi, G. Brandimarte, A. Papa, A. Giglio, W. Elisei, G.M. Giorgetti, and et al. Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study Am J Gastroenterol 105 2010 2218 2227
38. H.E. Mardini, and A.Y. Grigorian Probiotic mix VSL#3 is effective adjunctive therapy for mild to moderately active ulcerative colitis: a meta-analysis Inflamm Bowel Dis 20 2014 1562 1567
39. S.K. Hegazy, and M.M. El-Bedewy Effect of probiotics on pro-inflammatory cytokines and NF-kappaB activation in ulcerative colitis World J Gastroenterol WJG 16 2010 4145 4151
40. G. Li, S. Zeng, W. Liao, and N. Lv The effect of bifid triple viable on immune function of patients with ulcerative colitis Gastroenterol Res Pract 2012 2012 404752
41. E. Furrie, S. Macfarlane, A. Kennedy, J.H. Cummings, S.V. Walsh, D.A. O'Neil, and et al. Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial Gut 54 2005 242 249
42. K. Kato, S. Mizuno, Y. Umesaki, Y. Ishii, M. Sugitani, A. Imaoka, and et al. Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis Alimentary Pharmacol Ther 20 2004 1133 1141
43. P.I. Zigra, V.E. Maipa, and Y.P. Alamanos Probiotics and remission of ulcerative colitis: a systematic review Neth J Med 65 2007 411 418
44. M. Guslandi Saccharomyces boulardii plus rifaximin in mesalamine-intolerant ulcerative colitis J Clin Gastroenterol 44 2010 385
45. W. Kruis, P. Fric, J. Pokrotnieks, M. Lukas, B. Fixa, M. Kascak, and et al. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine Gut 53 2004 1617 1623
46. W. Kruis, E. Schutz, P. Fric, B. Fixa, G. Judmaier, and M. Stolte Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis Alimentary Pharmacol Ther 11 1997 853 858
47. A.K. Waljee, R.W. Stidham, P.D. Higgins, S. Vijan, and S.D. Saini Point-counterpoint: are we overtreating patients with mild ulcerative colitis? J Crohn's Colitis 8 2014 80 84
48. A. Venturi, P. Gionchetti, F. Rizzello, R. Johansson, E. Zucconi, P. Brigidi, and et al. Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis Alimentary Pharmacol Ther 13 1999 1103 1108
49. M.A. Zocco, L.Z. dal Verme, F. Cremonini, A.C. Piscaglia, E.C. Nista, M. Candelli, and et al. Efficacy of lactobacillus GG in maintaining remission of ulcerative colitis Alimentary Pharmacol Ther 23 2006 1567 1574
50. H. Ishikawa, S. Matsumoto, Y. Ohashi, A. Imaoka, H. Setoyama, Y. Umesaki, and et al. Beneficial effects of probiotic bifidobacterium and galacto-oligosaccharide in patients with ulcerative colitis: a randomized controlled study Digestion 84 2011 128 133
51. K. Naidoo, M. Gordon, A.O. Fagbemi, A.G. Thomas, and A.K. Akobeng Probiotics for maintenance of remission in ulcerative colitis Cochrane Database Syst Rev 2011 CD007443
52. Y. Bouhnik, L. Raskine, G. Simoneau, E. Vicaut, C. Neut, B. Flourie, and et al. The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: a double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study Am J Clin Nutr 80 2004 1658 1664
53. J. Ballongue, C. Schumann, and P. Quignon Effects of lactulose and lactitol on colonic microflora and enzymatic activity Scand J Gastroenterol Suppl 222 1997 41 44
54. L.B. Bindels, N.M. Delzenne, P.D. Cani, and J. Walter Towards a more comprehensive concept for prebiotics Nat Rev Gastroenterol Hepatol 12 2015 303 310
55. F. Fernandez-Banares, J. Hinojosa, J.L. Sanchez-Lombrana, E. Navarro, J.F. Martinez-Salmeron, A. Garcia-Puges, and et al. Randomized clinical trial of Plantago ovata seeds (dietary fiber) as compared with mesalamine in maintaining remission in ulcerative colitis. Spanish Group for the Study of Crohn's Disease and Ulcerative Colitis (GETECCU) Am J Gastroenterol 94 1999 427 433
56. F. Casellas, N. Borruel, A. Torrejon, E. Varela, M. Antolin, F. Guarner, and et al. Oral oligofructose-enriched inulin supplementation in acute ulcerative colitis is well tolerated and associated with lowered faecal calprotectin Alimentary Pharmacol Ther 25 2007 1061 1067
57. S. Fujimori, K. Gudis, K. Mitsui, T. Seo, M. Yonezawa, S. Tanaka, and et al. A randomized controlled trial on the efficacy of synbiotic versus probiotic or prebiotic treatment to improve the quality of life in patients with ulcerative colitis Nutrition 25 2009 520 525
58. M.H. Floch, W.A. Walker, M.E. Sanders, M. Nieuwdorp, A.S. Kim, D.A. Brenner, and et al. Recommendations for probiotic Use-2015 update: proceedings and consensus opinion J Clin Gastroenterol 49 Suppl. 1 2015 S69 S73
59. M. Guslandi, P. Giollo, and P.A. Testoni A pilot trial of Saccharomyces boulardii in ulcerative colitis Eur J Gastroenterol Hepatol 15 2003 697 698
60. Y. Tsuda, Y. Yoshimatsu, H. Aoki, K. Nakamura, M. Irie, K. Fukuda, and et al. Clinical effectiveness of probiotics therapy (BIO-THREE) in patients with ulcerative colitis refractory to conventional therapy Scand J Gastroenterol 42 2007 1306 1311
61. Y. Takeda, H. Nakase, K. Namba, S. Inoue, S. Ueno, N. Uza, and et al. Upregulation of T-bet and tight junction molecules by Bifidobactrium longum improves colonic inflammation of ulcerative colitis Inflamm Bowel Dis 15 2009 1617 1618
62. R. D'Inca, M. Barollo, M. Scarpa, A.R. Grillo, P. Brun, M.G. Vettorato, and et al. Rectal administration of Lactobacillus casei DG modifies flora composition and Toll-like receptor expression in colonic mucosa of patients with mild ulcerative colitis Dig Dis Sci 56 2011 1178 1187
63. S. Oliva, G. Di Nardo, F. Ferrari, S. Mallardo, P. Rossi, G. Patrizi, and et al. Randomised clinical trial: the effectiveness of lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis Alimentary Pharmacol Ther 35 2012 327 334
64. H. Ishikawa, I. Akedo, Y. Umesaki, R. Tanaka, A. Imaoka, and T. Otani Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis J Am Coll Nutr 22 2003 56 63
65. H.H. Cui, C.L. Chen, J.D. Wang, Y.J. Yang, Y. Cun, J.B. Wu, and et al. Effects of probiotic on intestinal mucosa of patients with ulcerative colitis World J Gastroenterol WJG 10 2004 1521 1525
66. S. Wildt, I. Nordgaard, U. Hansen, E. Brockmann, and J.J. Rumessen A randomised double-blind placebo-controlled trial with Lactobacillus acidophilus La-5 and Bifidobacterium animalis subsp. lactis BB-12 for maintenance of remission in ulcerative colitis J Crohn's Colitis 5 2011 115 121
67. O. Kanauchi, K. Mitsuyama, T. Homma, K. Takahama, Y. Fujiyama, A. Andoh, and et al. Treatment of ulcerative colitis patients by long-term administration of germinated barley foodstuff: multi-center open trial Int J Mol Med 12 2003 701 704
68. A. Hafer, S. Kramer, S. Duncker, M. Kruger, M.P. Manns, and S.C. Bischoff Effect of oral lactulose on clinical and immunohistochemical parameters in patients with inflammatory bowel disease: a pilot study BMC Gastroenterol 7 2007 36
69. C. Hallert, M. Kaldma, and B.G. Petersson Ispaghula husk may relieve gastrointestinal symptoms in ulcerative colitis in remission Scand J Gastroenterol 26 1991 747 750
70. H. Hanai, O. Kanauchi, K. Mitsuyama, A. Andoh, K. Takeuchi, I. Takayuki, and et al. Germinated barley foodstuff prolongs remission in patients with ulcerative colitis Int J Mol Med 13 2004 643 647